Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W
Institute of Pathology, University of Tübingen, FRG.
Nephron. 1990;55(3):242-50. doi: 10.1159/000185969.
We carried out a retrospective investigation in 220 patients to assess the influence of various parameters on the long-term course of membranoproliferative glomerulonephritis (MPGN) type I. 50 patients (23%) died during the follow-up period of 59 months on average, in another 57 (26%) end-stage renal failure developed. 54 patients (24%) suffered from chronic renal failure, stable renal function (creatinine below 1.3 mg/dl) was preserved in 59 patients (27%). 5 years after biopsy 49% of the patients had already died or needed regular dialysis treatment; after 10 years this proportion increased to 64%. Morphological findings: The outcome was--with the exception of focal crescent formations--not determined by the severity of glomerular changes; the survival rate, however, decreased significantly, if tubulointerstitial lesions were present as defined by acute renal failure, interstitial fibrosis or a combination of both. Clinical parameters: A progressive deterioration of renal function and an increasing number of renal deaths was noticed, when elevated serum creatinine levels at the time of biopsy and high blood pressure values during the follow-up period were observed. 26 patients died from hypertension, 18 of whom before reaching end-stage renal failure. Nephrotic syndrome and the degree of proteinuria as well as antiphlogistic and immunosuppressive treatment did not influence the prognosis of MPGN type I.
我们对220例患者进行了回顾性调查,以评估各种参数对Ⅰ型膜增生性肾小球肾炎(MPGN)长期病程的影响。平均59个月的随访期内,50例患者(23%)死亡,另有57例(26%)发展为终末期肾衰竭。54例患者(24%)患有慢性肾衰竭,59例患者(27%)肾功能保持稳定(肌酐低于1.3mg/dl)。活检后5年,49%的患者已经死亡或需要定期透析治疗;10年后,这一比例增至64%。形态学结果:除局灶性新月体形成外,肾小球病变的严重程度并不决定预后;然而,如果存在由急性肾衰竭、间质纤维化或两者共同定义的肾小管间质病变,则存活率会显著降低。临床参数:当观察到活检时血清肌酐水平升高以及随访期间血压值较高时,会注意到肾功能逐渐恶化以及肾性死亡人数增加。26例患者死于高血压,其中18例在达到终末期肾衰竭之前死亡。肾病综合征、蛋白尿程度以及抗炎和免疫抑制治疗均不影响Ⅰ型MPGN的预后。